G42 Healthcare CEO Discusses Progress on Phase III Vaccine Trials (19.08.20)

Abdul Karim Hanif, Rania Saadi, and Ahmad Dawud speak to Ashish Koshy, CEO of G42 Healthcare, about the details and progress on the world’s first Phase III trials of the inactivated COVID-19 vaccine. Listen to #Pulse95Radio in the UAE by tuning in on your radio (95.00 FM) or online on our website: www.pulse95radio.com ************************ Follow us on Social. www.facebook.com/pulse95radio www.twitter.com/pulse95radio www.instagram.com/pulse95radio